Display options
Share it on

CEN Case Rep. 2017 May;6(1):22-28. doi: 10.1007/s13730-016-0237-y. Epub 2016 Oct 03.

Antithyroid drug-associated MPO-ANCA-positive tubulointerstitial nephritis in a type 2 diabetes patient: a case report.

CEN case reports

Shinsuke Nishimura, Kazushi Nakao, Masaya Takeda, Ikuko Matsuura, Yoshihisa Nomura, Sonei Shojima, Yuriko Yamamura, Kazuyuki Fujita, Noriya Momoki, Keisuke Maruyama, Masahiro Yamamura, Makoto Hiramatsu

Affiliations

  1. Department of Internal Medicine, Okayama Saiseikai General Hospital, 2-25 Kokutai-cho, Kita-Ward, Okayama, Okayama, 700-8511, Japan. [email protected].
  2. Department of Internal Medicine, Okayama Saiseikai General Hospital, 2-25 Kokutai-cho, Kita-Ward, Okayama, Okayama, 700-8511, Japan.

PMID: 28509121 PMCID: PMC5438802 DOI: 10.1007/s13730-016-0237-y

Abstract

A 54-year-old man diagnosed with type 2 diabetes and hyperthyroidism was prescribed propylthiouracil (PTU) after the patient developed hepatic dysfunction on thiamazole. At 50 mg/day of PTU, he was stable with thyroid-stimulating hormone receptor and thyrotropic antibody titers remaining stable. After four years of taking PTU, he was referred to the Department of Nephrology due to a rapid increase in his serum creatinine (Cr) level. He showed impaired renal function (Cr 2.26 mg/dL; estimated glomerular filtration rate (eGFR), 25 mL/min). In addition, urinary β2-microglobulin (β2 MG) was increased to 71,980 μg/L and was positive for myeloperoxidase (MPO)-anti-neutrophil cytoplasmic antibody (ANCA) (33.9 U/mL). Gallium scintigraphy demonstrated a remarkable accumulation in both kidneys. The patient was diagnosed with tubulointerstitial nephritis based on a renal biopsy, the results of which suggested that it might have been induced by PTU. He was treated with prednisolone (PSL) at 30 mg/day. As a result, within two weeks, Cr, eGFR, and urinary β2 MG levels were progressively improved to 1.72 mg/dL, 34 mL/min, and 22,020 μg/L, respectively. Therefore, we tapered off the PSL with a dose of 5 mg/day after approximately one year. There have been no exacerbated renal function parameters. Although there are many reports on patients developing MPO-ANCA-positive crescentic glomerulonephritis after the administration of PTU, we report on a relatively rare case in which interstitial nephritis occurred after the administration of PTU.

Keywords: Hyperthyroidism; MPO-ANCA; Propylthiouracil; Tubulointerstitial nephritis; Type 2 diabetes

References

  1. Endocr Pract. 2002 Nov;8(6):457-469 - PubMed
  2. J Nephrol. 2009 May-Jun;22(3):417-20 - PubMed
  3. Kidney Int. 2012 Jun;81(12):1172-8 - PubMed
  4. J Rheumatol. 2007 Dec;34(12):2451-6 - PubMed
  5. Clin J Am Soc Nephrol. 2014 May;9(5):905-13 - PubMed
  6. Clin Nephrol. 1985 Aug;24(2):84-7 - PubMed
  7. Mod Rheumatol. 2003 Dec;13(4):305-12 - PubMed
  8. Clin Kidney J. 2015 Jun;8(3):343-50 - PubMed
  9. Nat Rev Endocrinol. 2013 Dec;9(12):724-34 - PubMed
  10. Lancet. 1993 Sep 11;342(8872):651-2 - PubMed
  11. Thyroid. 2000 Aug;10(8):713-6 - PubMed
  12. Rheumatology (Oxford). 2008 Oct;47(10):1515-20 - PubMed
  13. J Clin Endocrinol Metab. 1999 Jan;84(1):13-6 - PubMed
  14. Clin Exp Nephrol. 2009 Dec;13(6):605-13 - PubMed
  15. JAMA. 2015 Dec 15;314(23):2544-54 - PubMed
  16. Pediatr Nephrol. 2017 Apr;32(4):577-587 - PubMed

Publication Types